 | • レポートコード：QY2108PAL3853 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は気管支内ブロッカーの世界市場の現状について調査・分析し、2027年までの市場を予測しました。気管支内ブロッカーの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（シングルルーメンチューブ、ダブルルーメンチューブ）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・気管支内ブロッカーの世界市場概要 ・メーカー別の競争状況、市場シェア ・気管支内ブロッカーの種類別市場規模：シングルルーメンチューブ、ダブルルーメンチューブ ・気管支内ブロッカーの用途別市場規模：病院、クリニック、その他 ・北米の気管支内ブロッカー市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの気管支内ブロッカー市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの気管支内ブロッカー市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の気管支内ブロッカー市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの気管支内ブロッカー市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Teleflex、Cook Medical、Ambu、Daiken Medical Co Ltd、XNY Medical Technology、PROACT Medical ・気管支内ブロッカーのバリューチェーン・販売チャネル分析 ・気管支内ブロッカーの世界市場動向 |
Market Analysis and Insights: Global Endobronchial Blocker Market
The global Endobronchial Blocker market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Endobronchial Blocker Scope and Segment
Endobronchial Blocker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Endobronchial Blocker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Single Lumen Tube
Double Lumen Tube
Segment by Application
Hospital
Clinic
Other
By Company
Teleflex
Cook Medical
Ambu
Daiken Medical Co Ltd
XNY Medical Technology
PROACT Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Endobronchial Blocker Product Introduction
1.2 Market by Type
1.2.1 Global Endobronchial Blocker Market Size Growth Rate by Type
1.2.2 Single Lumen Tube
1.2.3 Double Lumen Tube
1.3 Market by Application
1.3.1 Global Endobronchial Blocker Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Endobronchial Blocker Sales Estimates and Forecasts 2016-2027
2.2 Global Endobronchial Blocker Revenue Estimates and Forecasts 2016-2027
2.3 Global Endobronchial Blocker Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Endobronchial Blocker Regions by Sales
2.4.1 Global Top Endobronchial Blocker Regions by Sales (2016-2021)
2.4.2 Global Top Endobronchial Blocker Regions by Sales (2022-2027)
2.5 Global Top Endobronchial Blocker Regions by Revenue
2.5.1 Global Top Endobronchial Blocker Regions by Revenue (2016-2021)
2.5.2 Global Top Endobronchial Blocker Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Endobronchial Blocker Sales by Manufacturers
3.1.1 Global Top Endobronchial Blocker Manufacturers by Sales (2016-2021)
3.1.2 Global Top Endobronchial Blocker Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Endobronchial Blocker Sales in 2020
3.2 Global Endobronchial Blocker Revenue by Manufacturers
3.2.1 Global Top Endobronchial Blocker Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Endobronchial Blocker Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Endobronchial Blocker Revenue in 2020
3.3 Global Endobronchial Blocker Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Endobronchial Blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Endobronchial Blocker Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Endobronchial Blocker Sales by Type
4.1.1 Global Endobronchial Blocker Historical Sales by Type (2016-2021)
4.1.2 Global Endobronchial Blocker Forecasted Sales by Type (2022-2027)
4.1.3 Global Endobronchial Blocker Sales Market Share by Type (2016-2027)
4.2 Global Endobronchial Blocker Revenue by Type
4.2.1 Global Endobronchial Blocker Historical Revenue by Type (2016-2021)
4.2.2 Global Endobronchial Blocker Forecasted Revenue by Type (2022-2027)
4.2.3 Global Endobronchial Blocker Revenue Market Share by Type (2016-2027)
4.3 Global Endobronchial Blocker Price by Type
4.3.1 Global Endobronchial Blocker Price by Type (2016-2021)
4.3.2 Global Endobronchial Blocker Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Endobronchial Blocker Sales by Application
5.1.1 Global Endobronchial Blocker Historical Sales by Application (2016-2021)
5.1.2 Global Endobronchial Blocker Forecasted Sales by Application (2022-2027)
5.1.3 Global Endobronchial Blocker Sales Market Share by Application (2016-2027)
5.2 Global Endobronchial Blocker Revenue by Application
5.2.1 Global Endobronchial Blocker Historical Revenue by Application (2016-2021)
5.2.2 Global Endobronchial Blocker Forecasted Revenue by Application (2022-2027)
5.2.3 Global Endobronchial Blocker Revenue Market Share by Application (2016-2027)
5.3 Global Endobronchial Blocker Price by Application
5.3.1 Global Endobronchial Blocker Price by Application (2016-2021)
5.3.2 Global Endobronchial Blocker Price Forecast by Application (2022-2027)
6 North America
6.1 North America Endobronchial Blocker Market Size by Type
6.1.1 North America Endobronchial Blocker Sales by Type (2016-2027)
6.1.2 North America Endobronchial Blocker Revenue by Type (2016-2027)
6.2 North America Endobronchial Blocker Market Size by Application
6.2.1 North America Endobronchial Blocker Sales by Application (2016-2027)
6.2.2 North America Endobronchial Blocker Revenue by Application (2016-2027)
6.3 North America Endobronchial Blocker Market Size by Country
6.3.1 North America Endobronchial Blocker Sales by Country (2016-2027)
6.3.2 North America Endobronchial Blocker Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Endobronchial Blocker Market Size by Type
7.1.1 Europe Endobronchial Blocker Sales by Type (2016-2027)
7.1.2 Europe Endobronchial Blocker Revenue by Type (2016-2027)
7.2 Europe Endobronchial Blocker Market Size by Application
7.2.1 Europe Endobronchial Blocker Sales by Application (2016-2027)
7.2.2 Europe Endobronchial Blocker Revenue by Application (2016-2027)
7.3 Europe Endobronchial Blocker Market Size by Country
7.3.1 Europe Endobronchial Blocker Sales by Country (2016-2027)
7.3.2 Europe Endobronchial Blocker Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Endobronchial Blocker Market Size by Type
8.1.1 Asia Pacific Endobronchial Blocker Sales by Type (2016-2027)
8.1.2 Asia Pacific Endobronchial Blocker Revenue by Type (2016-2027)
8.2 Asia Pacific Endobronchial Blocker Market Size by Application
8.2.1 Asia Pacific Endobronchial Blocker Sales by Application (2016-2027)
8.2.2 Asia Pacific Endobronchial Blocker Revenue by Application (2016-2027)
8.3 Asia Pacific Endobronchial Blocker Market Size by Region
8.3.1 Asia Pacific Endobronchial Blocker Sales by Region (2016-2027)
8.3.2 Asia Pacific Endobronchial Blocker Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Endobronchial Blocker Market Size by Type
9.1.1 Latin America Endobronchial Blocker Sales by Type (2016-2027)
9.1.2 Latin America Endobronchial Blocker Revenue by Type (2016-2027)
9.2 Latin America Endobronchial Blocker Market Size by Application
9.2.1 Latin America Endobronchial Blocker Sales by Application (2016-2027)
9.2.2 Latin America Endobronchial Blocker Revenue by Application (2016-2027)
9.3 Latin America Endobronchial Blocker Market Size by Country
9.3.1 Latin America Endobronchial Blocker Sales by Country (2016-2027)
9.3.2 Latin America Endobronchial Blocker Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Endobronchial Blocker Market Size by Type
10.1.1 Middle East and Africa Endobronchial Blocker Sales by Type (2016-2027)
10.1.2 Middle East and Africa Endobronchial Blocker Revenue by Type (2016-2027)
10.2 Middle East and Africa Endobronchial Blocker Market Size by Application
10.2.1 Middle East and Africa Endobronchial Blocker Sales by Application (2016-2027)
10.2.2 Middle East and Africa Endobronchial Blocker Revenue by Application (2016-2027)
10.3 Middle East and Africa Endobronchial Blocker Market Size by Country
10.3.1 Middle East and Africa Endobronchial Blocker Sales by Country (2016-2027)
10.3.2 Middle East and Africa Endobronchial Blocker Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teleflex
11.1.1 Teleflex Corporation Information
11.1.2 Teleflex Overview
11.1.3 Teleflex Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Teleflex Endobronchial Blocker Product Description
11.1.5 Teleflex Recent Developments
11.2 Cook Medical
11.2.1 Cook Medical Corporation Information
11.2.2 Cook Medical Overview
11.2.3 Cook Medical Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Cook Medical Endobronchial Blocker Product Description
11.2.5 Cook Medical Recent Developments
11.3 Ambu
11.3.1 Ambu Corporation Information
11.3.2 Ambu Overview
11.3.3 Ambu Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Ambu Endobronchial Blocker Product Description
11.3.5 Ambu Recent Developments
11.4 Daiken Medical Co Ltd
11.4.1 Daiken Medical Co Ltd Corporation Information
11.4.2 Daiken Medical Co Ltd Overview
11.4.3 Daiken Medical Co Ltd Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Daiken Medical Co Ltd Endobronchial Blocker Product Description
11.4.5 Daiken Medical Co Ltd Recent Developments
11.5 XNY Medical Technology
11.5.1 XNY Medical Technology Corporation Information
11.5.2 XNY Medical Technology Overview
11.5.3 XNY Medical Technology Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 XNY Medical Technology Endobronchial Blocker Product Description
11.5.5 XNY Medical Technology Recent Developments
11.6 PROACT Medical
11.6.1 PROACT Medical Corporation Information
11.6.2 PROACT Medical Overview
11.6.3 PROACT Medical Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 PROACT Medical Endobronchial Blocker Product Description
11.6.5 PROACT Medical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Endobronchial Blocker Value Chain Analysis
12.2 Endobronchial Blocker Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Endobronchial Blocker Production Mode & Process
12.4 Endobronchial Blocker Sales and Marketing
12.4.1 Endobronchial Blocker Sales Channels
12.4.2 Endobronchial Blocker Distributors
12.5 Endobronchial Blocker Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Endobronchial Blocker Industry Trends
13.2 Endobronchial Blocker Market Drivers
13.3 Endobronchial Blocker Market Challenges
13.4 Endobronchial Blocker Market Restraints
14 Key Findings in The Global Endobronchial Blocker Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Endobronchial Blocker Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Single Lumen Tube
Table 3. Major Manufacturers of Double Lumen Tube
Table 4. Global Endobronchial Blocker Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Endobronchial Blocker Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Endobronchial Blocker Sales by Region (2016-2021) & (K Units)
Table 7. Global Endobronchial Blocker Sales Market Share by Region (2016-2021)
Table 8. Global Endobronchial Blocker Sales by Region (2022-2027) & (K Units)
Table 9. Global Endobronchial Blocker Sales Market Share by Region (2022-2027)
Table 10. Global Endobronchial Blocker Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Endobronchial Blocker Revenue Market Share by Region (2016-2021)
Table 12. Global Endobronchial Blocker Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Endobronchial Blocker Revenue Market Share by Region (2022-2027)
Table 14. Global Endobronchial Blocker Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Endobronchial Blocker Sales Share by Manufacturers (2016-2021)
Table 16. Global Endobronchial Blocker Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Endobronchial Blocker Revenue Share by Manufacturers (2016-2021)
Table 18. Endobronchial Blocker Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Endobronchial Blocker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Endobronchial Blocker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endobronchial Blocker as of 2020)
Table 21. Endobronchial Blocker Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Endobronchial Blocker Product Offered
Table 23. Date of Manufacturers Enter into Endobronchial Blocker Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endobronchial Blocker Sales by Type (2016-2021) & (K Units)
Table 26. Global Endobronchial Blocker Sales by Type (2022-2027) & (K Units)
Table 27. Global Endobronchial Blocker Sales Share by Type (2016-2021)
Table 28. Global Endobronchial Blocker Sales Share by Type (2022-2027)
Table 29. Global Endobronchial Blocker Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Endobronchial Blocker Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Endobronchial Blocker Revenue Share by Type (2016-2021)
Table 32. Global Endobronchial Blocker Revenue Share by Type (2022-2027)
Table 33. Endobronchial Blocker Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Endobronchial Blocker Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Endobronchial Blocker Sales by Application (2016-2021) & (K Units)
Table 36. Global Endobronchial Blocker Sales by Application (2022-2027) & (K Units)
Table 37. Global Endobronchial Blocker Sales Share by Application (2016-2021)
Table 38. Global Endobronchial Blocker Sales Share by Application (2022-2027)
Table 39. Global Endobronchial Blocker Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Endobronchial Blocker Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Endobronchial Blocker Revenue Share by Application (2016-2021)
Table 42. Global Endobronchial Blocker Revenue Share by Application (2022-2027)
Table 43. Endobronchial Blocker Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Endobronchial Blocker Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Endobronchial Blocker Sales by Type (2016-2021) & (K Units)
Table 46. North America Endobronchial Blocker Sales by Type (2022-2027) & (K Units)
Table 47. North America Endobronchial Blocker Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Endobronchial Blocker Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Endobronchial Blocker Sales by Application (2016-2021) & (K Units)
Table 50. North America Endobronchial Blocker Sales by Application (2022-2027) & (K Units)
Table 51. North America Endobronchial Blocker Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Endobronchial Blocker Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Endobronchial Blocker Sales by Country (2016-2021) & (K Units)
Table 54. North America Endobronchial Blocker Sales by Country (2022-2027) & (K Units)
Table 55. North America Endobronchial Blocker Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Endobronchial Blocker Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Endobronchial Blocker Sales by Type (2016-2021) & (K Units)
Table 58. Europe Endobronchial Blocker Sales by Type (2022-2027) & (K Units)
Table 59. Europe Endobronchial Blocker Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Endobronchial Blocker Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Endobronchial Blocker Sales by Application (2016-2021) & (K Units)
Table 62. Europe Endobronchial Blocker Sales by Application (2022-2027) & (K Units)
Table 63. Europe Endobronchial Blocker Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Endobronchial Blocker Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Endobronchial Blocker Sales by Country (2016-2021) & (K Units)
Table 66. Europe Endobronchial Blocker Sales by Country (2022-2027) & (K Units)
Table 67. Europe Endobronchial Blocker Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Endobronchial Blocker Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Endobronchial Blocker Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Endobronchial Blocker Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Endobronchial Blocker Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Endobronchial Blocker Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Endobronchial Blocker Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Endobronchial Blocker Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Endobronchial Blocker Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Endobronchial Blocker Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Endobronchial Blocker Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Endobronchial Blocker Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Endobronchial Blocker Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Endobronchial Blocker Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Endobronchial Blocker Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Endobronchial Blocker Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Endobronchial Blocker Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Endobronchial Blocker Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Endobronchial Blocker Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Endobronchial Blocker Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Endobronchial Blocker Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Endobronchial Blocker Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Endobronchial Blocker Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Endobronchial Blocker Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Endobronchial Blocker Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Endobronchial Blocker Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Endobronchial Blocker Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Endobronchial Blocker Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Endobronchial Blocker Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Endobronchial Blocker Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Endobronchial Blocker Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Endobronchial Blocker Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Endobronchial Blocker Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Endobronchial Blocker Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Endobronchial Blocker Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Endobronchial Blocker Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Endobronchial Blocker Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Endobronchial Blocker Revenue by Country (2022-2027) & (US$ Million)
Table 105. Teleflex Corporation Information
Table 106. Teleflex Description and Major Businesses
Table 107. Teleflex Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Teleflex Endobronchial Blocker Product
Table 109. Teleflex Recent Developments
Table 110. Cook Medical Corporation Information
Table 111. Cook Medical Description and Major Businesses
Table 112. Cook Medical Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Cook Medical Endobronchial Blocker Product
Table 114. Cook Medical Recent Developments
Table 115. Ambu Corporation Information
Table 116. Ambu Description and Major Businesses
Table 117. Ambu Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Ambu Endobronchial Blocker Product
Table 119. Ambu Recent Developments
Table 120. Daiken Medical Co Ltd Corporation Information
Table 121. Daiken Medical Co Ltd Description and Major Businesses
Table 122. Daiken Medical Co Ltd Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Daiken Medical Co Ltd Endobronchial Blocker Product
Table 124. Daiken Medical Co Ltd Recent Developments
Table 125. XNY Medical Technology Corporation Information
Table 126. XNY Medical Technology Description and Major Businesses
Table 127. XNY Medical Technology Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. XNY Medical Technology Endobronchial Blocker Product
Table 129. XNY Medical Technology Recent Developments
Table 130. PROACT Medical Corporation Information
Table 131. PROACT Medical Description and Major Businesses
Table 132. PROACT Medical Endobronchial Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. PROACT Medical Endobronchial Blocker Product
Table 134. PROACT Medical Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Endobronchial Blocker Distributors List
Table 138. Endobronchial Blocker Customers List
Table 139. Endobronchial Blocker Market Trends
Table 140. Endobronchial Blocker Market Drivers
Table 141. Endobronchial Blocker Market Challenges
Table 142. Endobronchial Blocker Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Endobronchial Blocker Product Picture
Figure 2. Global Endobronchial Blocker Market Share by Type in 2020 & 2027
Figure 3. Single Lumen Tube Product Picture
Figure 4. Double Lumen Tube Product Picture
Figure 5. Global Endobronchial Blocker Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Endobronchial Blocker Report Years Considered
Figure 10. Global Endobronchial Blocker Sales 2016-2027 (K Units)
Figure 11. Global Endobronchial Blocker Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Endobronchial Blocker Revenue 2016-2027 (US$ Million)
Figure 13. Global Endobronchial Blocker Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Endobronchial Blocker Sales Market Share by Region (2016-2021)
Figure 15. Global Endobronchial Blocker Sales Market Share by Region (2022-2027)
Figure 16. North America Endobronchial Blocker Sales YoY (2016-2027) & (K Units)
Figure 17. North America Endobronchial Blocker Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Endobronchial Blocker Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Endobronchial Blocker Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Endobronchial Blocker Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Endobronchial Blocker Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Endobronchial Blocker Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Endobronchial Blocker Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Endobronchial Blocker Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Endobronchial Blocker Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Endobronchial Blocker Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Endobronchial Blocker Revenue in 2020
Figure 28. Endobronchial Blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Endobronchial Blocker Sales Market Share by Type (2016-2027)
Figure 30. Global Endobronchial Blocker Revenue Market Share by Type (2016-2027)
Figure 31. Global Endobronchial Blocker Sales Market Share by Application (2016-2027)
Figure 32. Global Endobronchial Blocker Revenue Market Share by Application (2016-2027)
Figure 33. North America Endobronchial Blocker Sales Market Share by Type (2016-2027)
Figure 34. North America Endobronchial Blocker Revenue Market Share by Type (2016-2027)
Figure 35. North America Endobronchial Blocker Sales Market Share by Application (2016-2027)
Figure 36. North America Endobronchial Blocker Revenue Market Share by Application (2016-2027)
Figure 37. North America Endobronchial Blocker Sales Share by Country (2016-2027)
Figure 38. North America Endobronchial Blocker Revenue Share by Country (2016-2027)
Figure 39. United States Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Endobronchial Blocker Sales Market Share by Type (2016-2027)
Figure 42. Europe Endobronchial Blocker Revenue Market Share by Type (2016-2027)
Figure 43. Europe Endobronchial Blocker Sales Market Share by Application (2016-2027)
Figure 44. Europe Endobronchial Blocker Revenue Market Share by Application (2016-2027)
Figure 45. Europe Endobronchial Blocker Sales Share by Country (2016-2027)
Figure 46. Europe Endobronchial Blocker Revenue Share by Country (2016-2027)
Figure 47. Germany Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 48. France Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Endobronchial Blocker Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Endobronchial Blocker Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Endobronchial Blocker Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Endobronchial Blocker Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Endobronchial Blocker Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Endobronchial Blocker Revenue Share by Region (2016-2027)
Figure 58. China Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 61. India Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Endobronchial Blocker Sales Market Share by Type (2016-2027)
Figure 68. Latin America Endobronchial Blocker Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Endobronchial Blocker Sales Market Share by Application (2016-2027)
Figure 70. Latin America Endobronchial Blocker Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Endobronchial Blocker Sales Share by Country (2016-2027)
Figure 72. Latin America Endobronchial Blocker Revenue Share by Country (2016-2027)
Figure 73. Mexico Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Endobronchial Blocker Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Endobronchial Blocker Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Endobronchial Blocker Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Endobronchial Blocker Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Endobronchial Blocker Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Endobronchial Blocker Revenue Share by Country (2016-2027)
Figure 82. Turkey Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Endobronchial Blocker Revenue (2016-2027) & (US$ Million)
Figure 85. Endobronchial Blocker Value Chain
Figure 86. Endobronchial Blocker Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
カルシウムチャネル遮断薬の世界及び中国市場 Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be pr…- アレルゲンブロッカーの世界市場 2020年 Market Overview The global Allergen Blocker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Allergen Blocker market repo…
- アレルゲンブロッカーの世界及び中国市場 Allergen Blocker is a product that delivers fast, effective protection against airborne allergens such as those from pollen, pets and dust mites. Allergen Blocker Air and Surface spray are safe for use on carpets, upholstery, clothes furniture & fabrics. The classification of Allergen Blocker includ…
- カルシウムチャンネルブロッカーの世界市場 2020年 Market Overview The Calcium Channel Blocker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- ロードブロッカーの世界市場 2020年 Market Overview The global Road Blocker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Road Blocker market report provi…